Close Menu

Notre Dame

The platform is designed to isolate exosomes from blood, then release their extracellular RNA cargo for analysis as biomarkers for diseases including cancer.

In PNAS this week: computational approach to bring together single-cell data, systems genetic analysis of Anopheles gambiae polymorphism, and more.

Anopholes stephensi

An international team sequenced and analyzed the genomes of 16 Anopholes mosquito species to unravel evolutionary relationships and adaptations offering hints to malaria parasite transmission.

Transposagen's expanded license with the University of Notre Dame, University of Florida, and the USDA will cover nearly all commercial applications, including as a tool for drug and biomarker discovery.

Under the Phenotypic Drug Discovery program, researchers from academia or biotech submit candidate compounds in specific therapeutic areas for Lilly to evaluate and profile. Participating organizations retain full IP rights to the compounds, but Lilly receives first rights to negotiate a broader collaboration or licensing agreement.

Eli Lilly, Cornell University, and the Kauffman Foundation's iBridge Network each unveiled web-based initiatives for facilitating tech transfer at last week's Association of University Technology Managers annual meeting.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.